SPOTLIGHT -
Top Infectious Disease News of the Week—Week of April 7, 2019
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Read More
What Do Long-Acting Injectables Offer Patients With HIV?
Brian Woodfall, MD, discusses how long-acting injectables offer a new treatment option for patients with HIV in terms of long-term therapy.
FDA Approves Dolutegravir/Lamivudine for Treatment-Naive Patients With HIV
Dolutegravir/lamivudine (Dovato) becomes the first 2-drug, fixed-dose complete treatment for treatment-naive patients with HIV.
Treating Pregnant Women With HIV
Saye Khoo, MD, advocates for a more appropriate, stratified, risk-based approach to prescribing dolutegravir in pregnant women.
Contagion® to Report on the ECCMID Conference in Amsterdam
Contagion® will be heading to Amsterdam, Netherlands, on Saturday, April 13, 2019, to report on the annual European Congress of Clinical Microbiology and Infectious Diseases conference.
Why Is It So Important to Continue to Develop New Antiretroviral Therapies?
Bluma Brenner, PhD, explains the driving factors behind the push for new antiretroviral drugs for HIV treatment.
The ID Pipeline: FDA Activity from the Week of March 31, 2019
Here is a look at infectious disease related US Food and Drug Administration news from the week of March 31, 2019.
Recalls That Should Be on Your Radar—Week of March 31, 2019
We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.
Top Infectious Disease News of the Week—March 31, 2019
Advancements in HIV Treatment and Prevention
Brian Woodfall, MD, shares his opinion on some of the biggest advancements in HIV treatment and prevention.
Paul Sax, MD, Reacts to Results of ATLAS & FLAIR Studies
Paul Sax, MD, reacts to the ATLAS and FLAIR studies on long-acting injectable therapy.
What Should Clinicians Know About Long-Acting Injectables?
Susan Swindells, MBBS, provides an overview of long-acting injectable cabotegravir + rilpivirine for clinicians.
The ID Pipeline: FDA Activity from the Week of March 24, 2019
Here is a look at infectious disease related US Food and Drug Administration news from the week of March 24, 2019.
Recalls That Should Be on Your Radar—Week of March 24, 2019
Top Infectious Disease News of the Week—March 24, 2019
Contagion® Launches Insights Program Featuring Experts on Measles, Vaccination, and Public Health
To shed light on the current measles outbreaks, Contagion® is launching a video series featuring the perspectives of 2 medical experts.
Why Is the Opioid Overdose Death Rate Higher in People With HIV?
Karin Bosh, PhD, explains why the opioid overdose death rate was higher in 2015 than in 2011 among people with HIV.
Implementing a PrEP Prediction Model
Julia Marcus, PhD, MPH, provides advice for health care systems looking to implement a model to identify potential PrEP candidates.
Botswana Beat Cohort Study and the Safety of Dolutegravir in Pregnancy
Ava Avalos, MD, details the effects of a dolutegravir-based regimen on pregnancy.
Recalls That Should Be on Your Radar—Week of March 17
Top Infectious Disease News of the Week—March 17, 2019
Successes of Point-of-Care Viral Load Testing
Paul Drain, MD, MPH, explains how point-of-care viral load testing was successful in providing rapid results to patients in a South African-based study.
Top 5 Key Takeaways from CROI 2019
CROI 2019 was held March 4-7, 2018, in Seattle, Washington. The conference featured results of new studies on a variety of HIV topics as well as advancements being made in the field. Here are 5 key takeaways from the meeting.
How Providers Can Help Prevent PrEP Resistance
Kavita Misra, PhD, MPH, explains how health care providers can help prevent PrEP resistance from growing by increasing screening for acute HIV infection.
Barriers to PrEP Use
Julia Marcus, PhD, MPH, discusses the barriers of PrEP use and how current prescribing guidelines are used in clinical practice.
Recalls That Should Be On Your Radar—Week of March 10, 2019
Top Infectious Disease News of the Week—March 10, 2019
Exploring the Link Between Antiretroviral Therapy and Weight Gain
Paul Sax, MD, details his research on integrase inhibitor-based regimens and weight gain.
Takeaways from CROI 2019: Part 2
From the London Patient to the DISCOVER trial and everything in between, HIV experts provide their biggest takeaways from CROI 2019, in the second part of our highlight reel.
The DISCOVER Study: Options for PrEP
Brad Hare, MD, explains how the findings of the DISCOVER study indicate that PrEP is no longer a one-size-fits-all situation.